Curiosin Gel 15g. For the treatment of chronic wounds. Used to treat and prevent

Description

Curiosin Gel 15g. H
yaluronic acid gel for wound, burns, acne, ulcer healing,
Curiosin is a wound care preparation designed for quality healing. Curiosin is capable of promoting physiological wound healing and preventing wound infection. Curiosin is composed principally of highly purified zinc hyaluronan, a proprietary complex of the essential skin constituent hyaluronan* biomolecule and zinc.
Clinical studies from different areas of use:
- chronic wounds (leg ulcers of various origin),
- acute wounds (surgical wounds, burns),
- mild-to-moderate form of acne vulgaris.
INTENDED USE:
For over-the-counter use:
superficial wounds such as minor trauma wounds (abrasions, lacerations, cuts), minor burns, mild-to-moderate form of acne vulgaris,
Under the supervision of a healthcare professional:
chronic wounds such as leg ulcers of different origin and decubitus
DIRECTIONS:
Minor trauma wounds.
Clean the wound surface with saline or water, wait until bleeding stops, and apply Curiosin in a thin layer (1mm of the Gel or 1 drop/cm2 of the Fluid) to the entire wound surface. Covering the wound is optional, you may let Curiosin dry on the surface or may cover the wound with a primary non-stick gauze dressing and a self-adhesive bandage. Repeat the process of wound cleansing, applying Curiosin and bandaging daily, in the case of heavily exuding wounds twice a day
Minor burns:
Cool the burnt surface with running cold water and apply Curiosin as instructed above.
Mild-to-moderate form of acne vulgaris (spots, pimples):
After cleansing gently rub Curiosin into the affected skin area twice daily (rub gently until completely absorbed to avoid dried remnants of the gel on the skin).
What undesirable effects may Curiosin have?
In some case local hypersensitivity (allergic reaction) may emerge.The following symptoms may occasionally occur at the beginning of use: redness, mild transient stinging or burning sensations, and local pain.
The following conditions were reported very rarely during clinical trials: hypergranulation and partial necrosis found only in a very limited area of the wound bed, but the causal relationship to Curiosin therapy has not been established.
The picture is for illustration only. The packaging can be changed by the manufacturer. All packs include English informational leaflet.